Harish Seethapathy
Overview
Explore the profile of Harish Seethapathy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
550
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ebrahimi N, Gholizadeh Ghozloujeh Z, Poyan Mehr A, Seethapathy H, Robson K, Waguespack D, et al.
Nephron
. 2025 Jan;
:1-6.
PMID: 39827877
No abstract available.
2.
Gupta S, Green-Lingren O, Bhimaniya S, Krokhmal A, Jacene H, Ostermann M, et al.
J Clin Invest
. 2024 Aug;
134(18).
PMID: 39115940
No abstract available.
3.
Gomez A, Gibson K, Seethapathy H
Adv Kidney Dis Health
. 2024 Jul;
31(4):267-274.
PMID: 39084752
Minimal change disease represents a common cause of nephrotic syndrome in both pediatric and adult patients. Although much remains to be discovered, there have been significant recent advancements in our...
4.
Hanna P, Ouyang T, Tahir I, Katz-Agranov N, Wang Q, Mantz L, et al.
J Cachexia Sarcopenia Muscle
. 2024 Apr;
15(3):1187-1198.
PMID: 38646842
Background: Creatinine-based estimated glomerular filtration rate (eGFR) may overestimate kidney function in patients with sarcopenia. While cystatin C-based eGFR (eGFR) is less affected by muscle mass, it may underestimate kidney...
5.
Selvaskandan H, Gee P, Seethapathy H
Adv Kidney Dis Health
. 2024 Feb;
31(1):28-36.
PMID: 38403391
Technological innovation has accelerated exponentially over the last 2 decades. From the rise of smartphones and social media in the early 2000s to the mainstream accessibility of artificial intelligence (AI)...
6.
Seethapathy H, Zhao S, Ouyang T, Passos C, Sarang A, Cheung P, et al.
NEJM Evid
. 2024 Feb;
2(10):EVIDoa2300107.
PMID: 38320180
BACKGROUND: In clinical practice, sodium correction rates are frequently limited in patients with severe hyponatremia to prevent neurologic complications. The implications of correction rates on overall mortality and length of...
7.
Wang Q, Seethapathy R, Ouyang T, Strohbehn I, Katz-Agranov N, Hanna P, et al.
Kidney Int Rep
. 2023 Dec;
8(12):2833-2837.
PMID: 38106586
No abstract available.
8.
Seethapathy H, Mistry K, Sise M
Immunol Rev
. 2023 Jul;
318(1):61-69.
PMID: 37482912
Immune checkpoint inhibitors (ICIs) have become a mainstay of cancer therapy, with over 80 FDA-approved indications. Used in a variety of settings and in combination with each other and with...
9.
Hanna P, Wang Q, Strohbehn I, Moreno D, Harden D, Ouyang T, et al.
JAMA Netw Open
. 2023 Jul;
6(7):e2321715.
PMID: 37405775
Importance: Serum creatinine-based estimated glomerular filtration rate (eGFRcr) may overestimate the glomerular filtration rate (GFR) in patients with cancer. Cystatin C-based eGFR (eGFRcys) is an alternative marker of GFR. Objective:...
10.
Seethapathy H, Herrmann S, Rashidi A
Semin Nephrol
. 2023 May;
42(6):151346.
PMID: 37137187
Immune checkpoint inhibitors (ICIs) are now established treatments for advanced cancer and their use is now ubiquitous. The high upside of ICIs is tempered by their toxicity profile affecting almost...